Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Antares Pharma: Approval of Xyosted on or before September 29, 2018 Is Highly Probable (ATRS, Buy, $2.12)

Background on Xyosted NDA Resubmission Following Complete Response Letter

The original PDUFA date for the Xyosted NDA was October 20, 2017,…
Read more…